Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics Using in Silico and in Vitro Methods by Elena Iemma | May 1, 2023Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics Using in silico and in vitro Methods
T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020 by Annie De Groot | Jun 30, 20202020 TCWP
Evaluating Immunogenicity Risk Due to Host Cell Protein Impurities in Antibody-Based Biotherapeutics by Sarah Moniz | Dec 22, 2017
